The Patent Finder

Azitra Inc

11 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes (US 11,773,154) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 1 fee due Jun 26, 2027
    The maintenance fee for Methods and compositions for treating skin disease with recombinant microorganisms (US 11,850,267) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,036,248Therapeutic Treatment of Skin Disease with Recombinant Commensal Skin Microorganisms
In force
 · High confidence
In forceHigh confidence
US 10,702,558Therapeutic Treatment of Skin Disease with Recombinant Commensal Skin Microorganisms
In force
 · High confidence
In forceHigh confidence
US 12,208,124Methods and Compositions for Treating Inflammatory Skin Disease with Recombinant Microorganisms
In force
 · High confidence
In forceHigh confidence
US 12,569,521Methods and Compositions for Treating Inflammatory Skin Disease with Recombinant Microorganisms
In force
 · High confidence
In forceHigh confidence
US 11,041,217Auxotrophic Strains of Staphylococcus Bacterium
In force
 · High confidence
In forceHigh confidence
US 12,606,610Compositions and Methods for Treatment of Netherton Syndrome with Lekti Expressing Recombinant Microbes
In force
 · Low confidence
In forceLow confidence
US 11,850,267Methods and compositions for treating skin disease with recombinant microorganisms
In force
 · USPTO record
In forceUSPTO record
US 12,702,684Methods and Compositions for Treating Skin Disease with Recombinant Microorganisms
In force
 · Low confidence
In forceLow confidence
US 11,773,154Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes
In force
 · USPTO record
In forceUSPTO record
US 12,503,691Auxotrophic Strains of Staphylococcus Bacterium
In force
 · Medium confidence
In forceMedium confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 2 abandoned · 1 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/735,645Therapeutic Treatment of Skin Disease with Recombinant Commensal Skin MicroorganismsJun 6, 2024Pending
18/599,588Auxotrophic Strains of Staphylococcus BacteriumMar 8, 2024Pending
18/362,205Methods and Compositions for Increasing Protein Expression in Genetically Engineered BacteriaJul 31, 2023Pending
17/320,471Auxotrophic Strains of Staphylococcus BacteriumMay 14, 2021Abandoned
17/089,367Nov 4, 2020No status recorded
17/089,220Compositions and Methods for Treatment or Prevention of Skin Diseases and Disorders with LektiNov 4, 2020Pending
16/839,995Methods and Compositions for Treating Atopic Dermatitis with Recombinant MicroorganismsApr 3, 2020Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited